Mounjaro Long-Term Side Effects: What the Evidence Currently Shows

Because tirzepatide (the active substance in Mounjaro) is a relatively recent prescription medicine, long-term data beyond two to three years is limited. Regulatory agencies continue to gather post-marketing safety information, and Mounjaro carries a black triangle (▼) status in the UK, meaning healthcare professionals and patients are encouraged to report any suspected side effects to their national reporting scheme — such as the UK's Yellow Card scheme — or the equivalent in their own country.

Commonly reported ongoing effects

Gastrointestinal symptoms — including nausea, constipation, diarrhoea, and reflux — are the most frequently reported side effects and are also among the most persistent for some people, though many find they ease significantly after the first few months or following a dose adjustment made by their prescriber. Fatigue and dizziness are also noted by some users over longer periods.

Areas under continued monitoring

• Thyroid: Animal studies identified a potential signal relating to thyroid C-cell changes with GLP-1 receptor agonists. Its relevance to humans has not been established, but it is a reason these medicines are not recommended for people with a personal or family history of medullary thyroid carcinoma. Your prescriber will have considered this before prescribing.
• Gallbladder: Rapid weight loss of any kind can increase the risk of gallstones. GLP-1 medicines may have a specific additional effect on gallbladder motility. Symptoms such as persistent upper-right abdominal pain should be reported to a healthcare professional promptly.
• Pancreatitis: Cases of pancreatitis have been reported with GLP-1 medicines. Severe or persistent abdominal pain is a reason to seek medical attention without delay.
• Muscle mass: Weight loss programmes, including those involving GLP-1 medicines, can result in loss of lean muscle alongside fat. Adequate protein intake and physical activity are commonly discussed strategies — something your prescriber or a dietitian can advise on in your specific situation.

Long-term effects across the GLP-1 class

Wegovy (semaglutide) has a longer post-market track record than Mounjaro, and patterns observed with semaglutide inform the broader understanding of long-term side effects of weight-loss injections more generally. You can also find specific information about side effects reported with Wegovy if that is relevant to your situation. For a broader overview of what Mounjaro users commonly experience, the full Mounjaro side effects guide covers the complete picture. Some people also have questions about the cancer-related signals that have been studied — a topic worth discussing directly with your prescriber.

According to NHS guidance, anyone experiencing symptoms they are concerned about while taking a GLP-1 medicine should contact their prescriber or doctor rather than waiting for a scheduled appointment.

One of the most practical things you can do over a long treatment course is build a consistent record of how you feel — not just in the first weeks, but month after month. Patterns that are invisible day-to-day become clear when you look back over a timeline of logged data.

GLP Trackr's side-effect tracker lets you log symptoms — nausea, fatigue, digestive changes, mood shifts, and more — each day, attaching them to your dose history so you can see how your experience shifts over time and across dose stages. That kind of longitudinal record is exactly what can make a prescriber appointment more productive: instead of trying to recall how you felt six weeks ago, you arrive with a clear summary already in hand. The app's doctor report feature compiles your logged data into a format designed to be shared with your healthcare team.

For longer journeys, the insights and analytics section can surface correlations — for example, whether sleep quality or protein intake tracks alongside how you feel on injection days — turning months of individual data points into something genuinely useful.

GLP Trackr is an informational and tracking tool. It does not replace your prescriber's advice, and any symptoms that are severe, persistent, or worrying should be discussed with your healthcare professional promptly — the app is there to help you record and communicate, not to interpret symptoms clinically.

You can also explore the dedicated long-term effects tracking guidance within GLP Trackr's resources for more on building a useful side-effect log over time.

Start building your record today — GLP Trackr is free to try for a full seven days on the App Store and Google Play, with no commitment needed to get started.